Acquired radioresistance in EMT6 mouse mammary carcinoma cell line is mediated by CTLA-4 and PD-1 through JAK/STAT/PI3K pathway
Cancer recurrence is often associated with the acquisition of radioresistance by cancer tissues due to failure in radiotherapy. The underlying mechanism leading to the development of acquired radioresistance in the EMT6 mouse mammary carcinoma cell line and the potential pathway involved was investi...
Published in: | Scientific Reports |
---|---|
Main Author: | Sham N.F.R.; Hasani N.A.H.; Hasan N.; Karim M.K.A.; Fuad S.B.S.A.; Hasbullah H.H.; Ibahim M.J. |
Format: | Article |
Language: | English |
Published: |
Nature Research
2023
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85148700448&doi=10.1038%2fs41598-023-29925-x&partnerID=40&md5=b1851d51af6b5d0738fd163d32985c3f |
Similar Items
-
Optimization of CTLA-4 and PD-1 proteins in EMT6 Mouse Mammary Cancer Cells by Western Blot
by: Sham N.F.R.; Hasani N.A.H.; Idorus M.Y.; Karim M.K.A.; Fuad S.B.S.A.; Hasbullah H.H.; Ibahim M.J.
Published: (2023) -
Different concentrations of nivolumab reduce PD-1 expression but not tumour growth in an EMT6 mouse model
by: Sham, et al.
Published: (2024) -
A single targeted gamma-ray irradiation induced an acute modulation of immune cells and related cytokines in EMT6 mouse-bearing tumour model
by: Hasan N.; Hasani N.A.H.; Omar E.; Sham F.R.; Fuad S.B.S.A.; Karim M.K.A.; Ibahim M.J.
Published: (2023) -
Development of flow cytometry analysis on measuring tumour immune microenvironment (TIME) in mice bearing EMT6 tumour model
by: Ibahim M.J.; Hasani N.A.H.; Sham F.R.; Omar E.; Fuad S.B.S.A.; Karim M.K.A.; Hasan N.
Published: (2022) -
Synchrotron microbeam radiotherapy evokes a different early tumor immunomodulatory response to conventional radiotherapy in EMT6.5 mammary tumors
by: Yang Y.; Swierczak A.; Ibahim M.; Paiva P.; Cann L.; Stevenson A.W.; Crosbie J.C.; Anderson R.L.; Rogers P.A.W.
Published: (2019)